Group 1 - The core point of the news is that 精优药业 announced a new share issuance to raise approximately 15.52 million HKD for potential business development in health products and related opportunities [1][2] - The company issued a total of 160 million shares to three different subscribers, with the share price set at 0.097 HKD, representing a discount of about 17.8% from the closing price on August 14, 2025 [1] - The funds raised will be used for the development of health products, equipment, and technology trade, as well as sales and distribution in China and potential overseas markets [2] Group 2 - The issuance is based on a general authorization granted by the shareholders' meeting, and the completion of the subscriptions is subject to certain conditions [2] - The shares issued to each subscriber represent a small percentage of the existing and enlarged share capital, with Subscriber I accounting for approximately 1.26% of the existing capital and 1.24% of the enlarged capital [1] - The completion of the subscriptions is expected to occur within 7 business days after the conditions are met [2]